Stran & Company, INC
Market Movers (8-K)
NASDAQ
Stran & Company announced strong first quarter 2026 financial results, with revenue up 8.9% year-over-year to $31.2 million and a significant swing to net income of $0.7 million.
Better than expected
NASDAQ
Stran & Company, Inc. announced it will host a conference call on May 13, 2026, to discuss its first quarter 2026 financial results and corporate progress.
NASDAQ
Stran & Company reported robust 40.6% year-over-year revenue growth to $116.2 million for fiscal year 2025, achieving positive EBITDA despite a modest net loss.
Better than expected
NASDAQ
Stran & Company, Inc. announced it will host a conference call on March 26, 2026, to discuss its 2025 fiscal year financial results and corporate developments.
NASDAQ
Stran & Company updates employment agreements for its CEO and CFO, and appoints a Chief Strategy and Compliance Officer to support growth and regulatory needs.
NASDAQ
Stran & Company, Inc. announced a 29.0% increase in third-quarter sales to $26.0 million and a significant reduction in net loss, driven by organic growth and the Gander Group acquisition.
Better than expected
Quarterly Earnings (10-Q)
NASDAQ
Stran & Company, Inc. reported significant revenue growth for Q3 and the first nine months of 2025, driven by the Gander Group acquisition, despite a decline in gross profit margins and negative operating cash flow.
Capital raise
Worse than expected
NASDAQ
Stran & Company, Inc. reported a significant increase in sales and a return to net income for the second quarter and first half of 2025, driven by organic growth and the Gander Group acquisition.
Better than expected
Capital raise
NASDAQ
Stran & Company's Q1 2025 sales surged by 52.4% year-over-year, driven by increased spending from existing clients and the acquisition of Gander Group.
Better than expected
NASDAQ
10-Q: Stran & Company Reports Q3 2024 Results, Restates Prior Financials Amidst Acquisition Integration
Stran & Company's Q3 2024 results show a net loss and restatement of prior financials due to accounting errors and acquisition integration.
Worse than expected
NASDAQ
Stran & Company's Q2 2024 results show a sales decrease of 4.1% compared to Q2 2023, alongside the announcement of a factoring arrangement, the acquisition of Bangarang Enterprises, and a new lease agreement.
Worse than expected
NASDAQ
Stran & Company's Q1 2024 sales increased by 17.9% year-over-year, but the company restated prior financials and acquired Bangarang Enterprises.
Worse than expected
Annual Reports (10-K)
NASDAQ
Stran & Company, Inc. reported a 40.6% increase in total sales to $116.2 million for 2025, narrowing its net loss to $0.7 million from $4.1 million in 2024, driven by client spending and strategic acquisitions.
Capital raise
NASDAQ
Stran & Company's 2024 10-K filing reveals an 8.8% increase in sales offset by a net loss due to rising operating expenses, acquisition costs, and identified material weaknesses in internal controls.
Worse than expected
NASDAQ
Stran & Company restated its financial statements for 2022 and 2023 due to accounting errors related to business combinations and other items, leading to a reassessment of internal controls.
Worse than expected
NASDAQ
Stran & Company, Inc.'s 10-K filing provides a detailed overview of its capital stock, warrants, options, and anti-takeover provisions, along with financial results for the year ended December 31, 2023.
Better than expected
Insider Trading (Form 4)
NASDAQ
Stran & Company, Inc.'s Chief Sales Officer and Chief Compliance Officer, John Audibert, acquired 100,000 shares of common stock.
NASDAQ
Stran & Company's CFO, David Browner, acquired 120,000 shares of common stock on November 26, 2025, increasing his beneficial ownership to 132,500 shares.
NASDAQ
Stran & Company's President and CEO, Andrew Shape, acquired 100,000 shares of common stock at $1.47 per share in a pre-planned transaction.
Better than expected
NASDAQ
John Audibert, VP of Growth & Strategic Initiatives at Stran & Company, Inc., acquired 4,500 shares of common stock through multiple open market purchases on June 27, 2025, increasing his direct beneficial ownership to 112,750 shares.
Better than expected
NASDAQ
Stran & Company, Inc. Director Alan Chippindale was granted 9,449 shares of common stock and 10,000 stock options, aligning his interests with shareholders through future vesting schedules.
Better than expected
NASDAQ
Stran & Company, Inc. Director Alan Chippindale reported the future acquisition of 20,000 shares of common stock at a price of $0, effective June 11, 2025, as part of a Rule 10b5-1 plan, increasing his direct beneficial ownership to 30,892 shares.
Proxy Statements (Def-14A)
NASDAQ
Stran & Company, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for August 24, 2026, detailing proposals for director elections and auditor ratification.
NASDAQ
STRAN & COMPANY, INC. announces its Annual Meeting of Stockholders for July 25, 2025, to elect directors and ratify its independent accounting firm.
NASDAQ
DEF: Stran & Company Faces Governance Scrutiny Amidst Auditor Instability and Internal Control Weaknesses
Stran & Company, Inc. will hold a combined 2024 and 2025 Annual Meeting to elect directors and ratify its new independent accounting firm, CBIZ CPAs P.C., following multiple auditor changes and disclosures of material weaknesses in internal financial controls.
Worse than expected
Delay expected
Schedule 13G - Passive Investments
NASDAQ
Alta Partners LLC has reported a 7.6% beneficial ownership stake in Stran & Company, Inc., primarily through shares issuable upon warrant exercise.
NASDAQ
Alta Partners LLC has reported a beneficial ownership of 5.09% of Stran & Company, Inc.'s common stock as of June 1, 2022.
NASDAQ
Andrew Shape has increased his beneficial ownership in Stran & Company, Inc. to 19.6% of common stock, with a significant portion pledged as collateral.
NASDAQ
Andrew Stranberg, a key insider, has increased his beneficial ownership in Stran & Company, Inc. to 29.8% of the common stock.